| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |